Prawo i regulacje · 08/11/2019

FDA Schedules Solriamfetol as a Schedule IV Controlled Substance

The US Food and Drug Administration has placed solriamfetol, a medication used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, in Schedule IV of the Controlled Substances Act, indicating its potential for abuse and dependence.